Skip to main content
Year archive

Alkem Laboratories Limited — 2025 filings

All 321 regulatory filings released by Alkem Laboratories Limited (ALKEM) in 2025, sourced directly from the official regulator.

321 Filings
2025 Period
2025 filings (321)
Filing Released Lang
General Updates
Capital/Financing Update
2025-12-30 English
Please find attached herewith Disclosure under Regulation 30 of SEBI LODR- Update on transfer of the trade generics business of the company.
Regulatory Filings
2025-12-30 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-30 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-30 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-30 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-30 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-30 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-30 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-29 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-29 English
Please find attached herewith Disclosure under Regulation 30 of SEBI LODR Regulations 2015.
Regulatory Filings
2025-12-26 English
General Updates
Capital/Financing Update
2025-12-26 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-26 English
Action(s) initiated or orders passed
Regulatory Filings
2025-12-26 English
This is to inform you that the trading window will remain closed from 30th December 2025 until the expiry of 48 hours after the date on which the financial results of the Company for the ....
Regulatory Filings
2025-12-23 English
Trading Window
Regulatory Filings
2025-12-23 English
Please find attached herewith Schedule of Analyst/Investor Meet.
Regulatory Filings
2025-12-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-12-23 English
This is to inform you that Mr. Suresh Sawant has been appointed at Senior Management Position in the company effective from 16th December 2025.
Regulatory Filings
2025-12-16 English
Appointment
Board/Management Information
2025-12-16 English
Please find herewith Schedule of Analyst/Investor meetings.
Regulatory Filings
2025-12-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-12-15 English
Cessation
Board/Management Information
2025-12-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-12-12 English
This is to inform you that Mr. Vijay Shetty shall cease to hold Senior Management Position of the company effective from 12th December 2025.
Regulatory Filings
2025-12-12 English
Please find attached herewith a copy of Newspaper Advertisement published today.
Regulatory Filings
2025-12-12 English
General Updates
Regulatory Filings
2025-12-10 English
Closure of GMP Inspection by Malta Medicines Authority at Company''s manufacturing facility located at Daman, India.
Regulatory Filings
2025-12-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-12-08 English
Please find attached herewith schedule of Analyst/Investor meetings.
Regulatory Filings
2025-12-08 English
Cessation
Board/Management Information
2025-12-08 English
This is to inform you that Mr. Rakesh Tripathi shall cease to hold Senior Management Position of the Company effective from 8th December, 2025.
Regulatory Filings
2025-12-08 English
This is to inform you that Mr. Prakash Ramnani has been appointed at senior management position in the company effective from 05th December 2025.
Regulatory Filings
2025-12-05 English
This is to inform you that Mr. Prakash Ramnani has been appointed at senior management position in the company effective from 05th December,2025.
Regulatory Filings
2025-12-05 English
Appointment
Board/Management Information
2025-12-05 English
Please find attached herewith Disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2025-12-04 English
Action(s) initiated or orders passed
Legal Proceedings Report
2025-12-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-12-03 English
Schedule of Analyst / Investor Meet - Intimation
Regulatory Filings
2025-12-03 English
Please find enclosed herewith Sustainability Report for Financial year 2024-25.
Regulatory Filings
2025-12-02 English
General Updates
Regulatory Filings
2025-12-02 English
Schedule of Analyst / Investor Meet - Intimation
Regulatory Filings
2025-11-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-25 English
General Updates
Regulatory Filings
2025-11-22 English
Closure of GMP Inspection by Ministry of Health, Armenia at the Company''s manufacturing facility located at Sikkim, India.
Regulatory Filings
2025-11-22 English
Press Release - ALkem launches probiotic "DSS", the original De Simone formulation, in India for gut health management
Regulatory Filings
2025-11-20 English
Press Release
Regulatory Filings
2025-11-20 English
Q2 & H1 FY26 - Earnings Conference Call Transcript
Regulatory Filings
2025-11-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-11-19 English
Pursuant to Regulation 30 of SEBI LODR Regulation,2025 this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act,2017. ....
Regulatory Filings
2025-11-18 English
Action(s) initiated or orders passed
Regulatory Filings
2025-11-18 English
Copy of Newspaper Publication
Regulatory Filings
2025-11-14 English
Newspaper Advertisement- Disclosure under Regulation 30
Regulatory Filings
2025-11-14 English
Please find enclosed herewith the details of the Analyst / Institutional Investor meetings.
Regulatory Filings
2025-11-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-14 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q2 & H1FY26 Earnings Conference Call'' is ....
Regulatory Filings
2025-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-11-13 English
The financial results of the Company for the quarter and half year ended 30th September, 2025 having been communicated to the Stock Exchanges today, i.e. 13th November, 2025, the trading ....
Regulatory Filings
2025-11-13 English
Trading Window
Regulatory Filings
2025-11-13 English
Pls find enclosed herewith the press release and analyst presentation on Q2 and H1FY26 earnings and business updates of the Company.
Regulatory Filings
2025-11-13 English
Investor Presentation
Interim / Quarterly Report
2025-11-13 English
Pls find enclosed herewith the Unaudited Financial Results along with the LRR for the quarter and half year ended 30 September, 2025.
Regulatory Filings
2025-11-13 English
Outcome of Board Meeting
Regulatory Filings
2025-11-13 English
Outcome of Board Meeting
Regulatory Filings
2025-11-13 English
Pls find enclosed the Outcome of Board Meeting dated 13.11.2025. Kindly take the same on record.
Regulatory Filings
2025-11-13 English
General Updates
Regulatory Filings
2025-11-10 English
Closure of EU GMP inspection by German Health Authority at Alkem''s manufacturing facility located at Baddi, India
Regulatory Filings
2025-11-10 English
Action(s) taken or orders passed
Regulatory Filings
2025-11-03 English
Pursuant to Regulation 30 read with SEBI LODR regulations, this is to inform you that the Company has received order passed by statutory authority under the Goods and Service Tax Act, 2017. ....
Regulatory Filings
2025-11-03 English
Press Release (Revised)
Regulatory Filings
2025-11-03 English
Press Release- Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines
Regulatory Filings
2025-11-03 English
Press Release
Regulatory Filings
2025-11-03 English
Press Release - Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines.
Regulatory Filings
2025-11-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-10-28 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY26 ....
Regulatory Filings
2025-10-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-10-28 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY26 ....
Regulatory Filings
2025-10-28 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-23 English
Board Meeting — Financial Results
Regulatory Filings
2025-10-23 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2025-10-23 English
Pursuant to Regulation 30 read with SEBI LODR Regulations, this is to inform you that the Company has received an appeal order passed by statutory authority under the Goods and Services ....
Regulatory Filings
2025-10-01 English
Action(s) initiated or orders passed
Regulatory Filings
2025-10-01 English
This is to inform you that today i.e. 26th September, 2025, the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited, a wholly owned subsidiary of the Company ....
Regulatory Filings
2025-09-26 English
General Updates
Capital/Financing Update
2025-09-26 English
Trading Window
Regulatory Filings
2025-09-25 English
This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for ....
Regulatory Filings
2025-09-25 English
Resignation
Board/Management Information
2025-09-25 English
This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from ....
Regulatory Filings
2025-09-25 English
Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-09-24 English
Action(s) initiated or orders passed
Regulatory Filings
2025-09-24 English
Action(s) initiated or orders passed
Regulatory Filings
2025-09-22 English
Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-09-22 English
This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release ....
Regulatory Filings
2025-09-22 English
Press Release
Capital/Financing Update
2025-09-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-18 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September, 2025, 26th September, 2025 and 30th September, 2025.
Regulatory Filings
2025-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-17 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 22nd September, 2025.
Regulatory Filings
2025-09-17 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 22nd September, 2025 and 25th September, 2025.
Regulatory Filings
2025-09-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-16 English
In continuation to our intimation dated 03rd September, 2025, this is to inform that, the Analyst / Investor meeting as scheduled to be held on Tuesday, 09th September, 2025, has been cancelled.
Regulatory Filings
2025-09-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-08 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 12th September, 2025, 17th September, 2025, 18th September, 2025, 19th September, 2025 and 23rd September, 2025.
Regulatory Filings
2025-09-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-09-03 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 09th September, 2025.
Regulatory Filings
2025-09-03 English
Details regarding the brief proceedings of the 51st AGM and the voting results of the business transacted thereat along with the Report of the Scrutinizer on remote e-voting and e-voting ....
Regulatory Filings
2025-08-25 English
Details regarding the brief proceedings of the 51st AGM of the Company and voting results of the business transacted thereat alongwith the report of the Scrutinizer on remote e-voting and ....
Regulatory Filings
2025-08-25 English
Shareholders meeting
Regulatory Filings
2025-08-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2025-08-22 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 28th August, 2025 and 03rd September, 2025.
Regulatory Filings
2025-08-22 English
Press Release
Regulatory Filings
2025-08-19 English
This is to inform you that the Company has announced the launch of Olesoft Trucera moisturizing lotion, an advanced science-led formulation designed to restore hydration, strengthen the ....
Regulatory Filings
2025-08-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-08-19 English
Please find enclosed herewith the transcript of "Q1 FY2026 Earnings conference call" hosted by the Company on Tuesday, 12th August, 2025.
Regulatory Filings
2025-08-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-08-12 English
Please find enclosed herewith link for Audio Recording of Earnings Call for Q1FY26
Regulatory Filings
2025-08-12 English
Trading Window
Regulatory Filings
2025-08-12 English
Investor Presentation
Interim / Quarterly Report
2025-08-12 English
General Updates
Capital/Financing Update
2025-08-12 English
The Financial Results of the Company for the quarter ended 30th June, 2025 having been communicated to the Stock Exchange today the trading window shall open on 18th Aug, 2025
Regulatory Filings
2025-08-12 English
Please find enclosed press release and analyst presentation on Q1FY26 earnings and business updates of the Company.
Regulatory Filings
2025-08-12 English
Company has pursuant to shareholders agreement dated 12th Aug, 2025 agreed to incorporate a subsidiary Company in the Kingdom of Saudi Arabia.
Regulatory Filings
2025-08-12 English
Outcome of Board Meeting
Regulatory Filings
2025-08-12 English
Please find enclosed herewith unaudited financial results along with LRR for quarter ended 30th June, 2025.
Regulatory Filings
2025-08-12 English
Outcome of Board Meeting
Regulatory Filings
2025-08-12 English
Please find enclosed herewith outcome of the BM dated 12th Aug, 25. The meeting of BOD started at 11 am and concluded at 1.25 pm.
Regulatory Filings
2025-08-12 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 20th August, 2025.
Regulatory Filings
2025-08-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-08-11 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and our earlier intimation dated 05th August, 2025, we write to inform ....
Regulatory Filings
2025-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-08-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1 FY26 financial ....
Regulatory Filings
2025-08-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-08-05 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-04 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
Regulatory Filings
2025-08-04 English
Board Meeting — Financial Results
Regulatory Filings
2025-08-04 English
Please find attached herewith the details regarding the voting results of the business transacted through the Postal Ballot by e-voting process in the prescribed format along with the Scrutinizers ...
Regulatory Filings
2025-08-04 English
Please find attached herewith the details of regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format along with ....
Regulatory Filings
2025-08-04 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2025-08-04 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-07-25 English
Action(s) initiated or orders passed
Regulatory Filings
2025-07-25 English
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement ....
Regulatory Filings
2025-07-22 English
Copy of Newspaper Publication
AGM Information
2025-07-22 English
Please find enclosed herewith the Business Responsibility and Sustainability Report for the financial year ended 31st march, 2025.
Regulatory Filings
2025-07-21 English
Please find attached herewith the Notice of AGM alongwith the Annual Report for FY 2024-15
Regulatory Filings
2025-07-21 English
Please find enclosed herewith the Notice of the 51st Annual General Meeting of the Company scheduled to be held on Monday, 25th August, 2025 at 11.00 a.m. through Video Conferencing (VC)/ ....
Regulatory Filings
2025-07-21 English
Shareholders meeting
Annual Report
2025-07-21 English
Pursuant to the provisions of Regulation 31A(8)(d) of the SEBI LODR Regulations, 2015, as amended, we wish to inform you that the Stock Exchanges, vide their respective letters dated 15th ....
Regulatory Filings
2025-07-16 English
General Updates
Regulatory Filings
2025-07-16 English
Please find attached herewith the details of regarding the voting results of the businesses transacted through Postal Ballot by remote e-voting process in the prescribed format along with ....
Regulatory Filings
2025-07-14 English
Please find attached herewith the details regarding the voting results of the businesses transacted through the Postal Ballot by e voting process in the prescribed format along with the ....
Regulatory Filings
2025-07-14 English
Shareholders meeting
Regulatory Filings
2025-07-14 English
Change in Director(s)
Board/Management Information
2025-07-08 English
Pursuant to Regulation 30 of the SEBI LODR Regulations, we wish to inform you that Mr. Arun Kumar Purwar (DIN: 00026383), Ms. Sudha Ravi (DIN: 06764496) and Ms. Sangeeta Singh ....
Regulatory Filings
2025-07-08 English
Copy of Newspaper Publication
AGM Information
2025-07-04 English
Pursuant to Regulation 47 of SEBI LODR Regulations, please find attached herewith a copy of the advertisement published in today''s newspaper viz. Business Standard (English) and Mumbai ....
Regulatory Filings
2025-07-04 English
Copy of Newspaper Publication
AGM Information
2025-07-03 English
Pursuant to Regulation 47 of SEBI LODR Regulation, please find attached herewith a copy of the advertisement published in today''s newspaper viz. Business Standard (English) and Mumbai ....
Regulatory Filings
2025-07-03 English
Shareholders meeting
Proxy Solicitation & Information Statement
2025-07-03 English
Please find attached herewith the Postal Ballot Notice dated 18th June, 2025, for the business as specified in the said Notice.
Regulatory Filings
2025-07-03 English
Trading Window
Regulatory Filings
2025-06-27 English
This is to inform you that the trading window will remain closed from 29th June, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for quarter ....
Regulatory Filings
2025-06-27 English
Copy of Newspaper Publication
Regulatory Filings
2025-06-24 English
Pursuant to Regulation 47 of SEBI LODR, please find enclosed herewith a copy of advertisement published in today''s newspaper viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) ....
Regulatory Filings
2025-06-24 English
General Updates
Regulatory Filings
2025-06-23 English
In continuation of our earlier intimation letter dated 07th January, 2025, we wish to inform you that today i.e. on 23rd June, 2025, the sale and transfer of the Company's manufacturing ....
Regulatory Filings
2025-06-23 English
Change in Director(s)
Board/Management Information
2025-06-18 English
The Board of Directors at its meeting held today i.e. 18th June, 2025 has approved the appointment of Mr. Diwakar Gupta as an Independent Director of the Company for a term of 5 consecutive ....
Regulatory Filings
2025-06-18 English
Action(s) initiated or orders passed
Legal Proceedings Report
2025-06-13 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an order passed by the statutory authority under Goods and Services Tax Act, ....
Regulatory Filings
2025-06-13 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-13 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement
2025-06-13 English
Please find enclosed herewith a copy of the newspaper advertisement published in today''s newspapers regards Postal Ballot Notice and e-voting information.
Regulatory Filings
2025-06-13 English
Shareholders meeting
Proxy Solicitation & Information Statement
2025-06-12 English
Please find attached herewith the Postal Ballot Notice dated 29th May, 2025, for the businesses as specified in the said notice.
Regulatory Filings
2025-06-12 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 18th June, 2025.
Regulatory Filings
2025-06-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-11 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 17th June, 2025.
Regulatory Filings
2025-06-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-06 English
Please find enclosed herewith the details of investors meetings scheduled to be held on 11th June, 2025 and 13th June 2025.
Regulatory Filings
2025-06-06 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an order passed by the statutory authority under Goods and Services Tax Act, ....
Regulatory Filings
2025-06-06 English
Action(s) initiated or orders passed
Regulatory Filings
2025-06-06 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Regulatory Filings
2025-06-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-06-02 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 06th June, 2025
Regulatory Filings
2025-06-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-06-02 English
Please find enclosed herewith the transcript of "Q4 FY2025 Earnings Conference Call" hosted by the Company on Thursday, 29th May, 2025.
Regulatory Filings
2025-06-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-29 English
Please find enclosed herewith link for Audio Recording of Earnings Call for Q4FY25
Regulatory Filings
2025-05-29 English
Annual Secretarial Compliance Report for the period ended 31st March, 2025
Regulatory Filings
2025-05-29 English
Trading Window
Regulatory Filings
2025-05-29 English
Updates
Regulatory Filings
2025-05-29 English
Investor Presentation
Earnings Release
2025-05-29 English
The Financial Results for quarter and year ended 31st March 2025 having been communicated to the Stock Exchanges today 29th May , the trading window shall open on 2nd June, 2025.
Regulatory Filings
2025-05-29 English
Please find enclosed press release and analyst presentation on Q4FY25 and FY25 earnings and business updates of the Company
Regulatory Filings
2025-05-29 English
Record Date
Regulatory Filings
2025-05-29 English
The BOD fixed 8th Aug 25 as record date for final dividend payment and 18th Aug as cut off for AGM.
Regulatory Filings
2025-05-29 English
General Updates
Regulatory Filings
2025-05-29 English
THE BOD recommended final dividend of Rs. 8 per equity share of Rs. 2 each for FY ended 31.03.25
Regulatory Filings
2025-05-29 English
Change in Director(s)
Board/Management Information
2025-05-29 English
Appt of M/s. Manish Ghia & associates, PCS as secretarial auditors for a term of 5 years w.ef 1st April 25 upto 31st march 2030 subject to approval of shareholders at the ensuing AGM
Regulatory Filings
2025-05-29 English
The BOD approved the appointment of Mr. Ranjal Shenoy and Ms. Neela Bhattercherjee as an Independent Director for a term of 5 consecutive years wef 13th July, 2025.
Regulatory Filings
2025-05-29 English
Dividend
Regulatory Filings
2025-05-29 English
Outcome of Board Meeting
Regulatory Filings
2025-05-29 English
Please find enclosed Audited Financial Results along with Auditors Report for FY ended 31st march 25
Regulatory Filings
2025-05-29 English
Outcome of Board Meeting
Regulatory Filings
2025-05-29 English
Please find enclosed herewith the Outcome of Board Meeting dated 29th May, 2025. The meeting of the Board of Directors of the Company commenced at 11.25 a.m. and concluded at 13.45 p.m. Kind
Regulatory Filings
2025-05-29 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 03rd June, 2025
Regulatory Filings
2025-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-27 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY25 and ....
Regulatory Filings
2025-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-05-19 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-16 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-05-16 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2025-05-16 English
General Updates
Regulatory Filings
2025-05-15 English
Enclosed herewith is the disclosure with respect to a cyber security incident involving a US subsidiary of Enzene Biosciences Limited, a subsidiary of the Company.
Regulatory Filings
2025-05-15 English
General Updates
M&A Activity
2025-04-23 English
In continuation of our earlier intimations dated 07th February, 2025 and 28th March, 2025, we wish to inform you that today i.e. 23rd April, 2025, the acquisition of Adroit by the Company ....
Regulatory Filings
2025-04-23 English
In continuation of our earlier intimations dated 07th February, 2025 and 15th March, 2025, we wish to inform you that today i.e. 16th April, 2025, the acquisition of Bombay Ortho by Alkem ....
Regulatory Filings
2025-04-16 English
General Updates
Capital/Financing Update
2025-04-16 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-08 English
Retirement
Board/Management Information
2025-03-31 English
This is to inform you that Mr. Adil Billimoria, Senior Management Personnel of the Company shall retire from the Company with effect from closing of business hours of 31st March, 2025.
Regulatory Filings
2025-03-31 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received orders passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-03-28 English
Action(s) initiated or orders passed
Regulatory Filings
2025-03-28 English
In continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 28th March, 2025, a share purchase agreement has been executed, inter alios, amongst ....
Regulatory Filings
2025-03-28 English
General Updates
M&A Activity
2025-03-28 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-03-25 English
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Madhurima Singh
Regulatory Filings
2025-03-25 English
Trading Window
Regulatory Filings
2025-03-24 English
This is to inform you that the trading window will remain closed from 30th March, 2025 until the expiry of 48 hours after the date on which the financial results of the Company for quarter ....
Regulatory Filings
2025-03-24 English
Please find enclosed herewith the details of investor meeting scheduled to be held on 28th March, 2025.
Regulatory Filings
2025-03-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-03-20 English
Investor Presentation
Investor Presentation
2025-03-19 English
Please find enclosed herewith the presentation with respect to the Investor / Analyst Meeting scheduled to be held at ''HSBC Global Investment Summit 2025'' on 24th March, 2025 and 25th ....
Regulatory Filings
2025-03-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-03-18 English
Please find enclosed herewith the details of investors meetings scheduled to be held on 27th March, 2025 and 28th March, 2025.
Regulatory Filings
2025-03-18 English
General Updates
M&A Activity
2025-03-15 English
In continuation of our earlier intimation dated 07th February, 2025, we wish to inform you that today i.e. 15th March, 2025, a share purchase and share subscription agreement has been executed, ....
Regulatory Filings
2025-03-15 English
Press Release
Regulatory Filings
2025-03-13 English
This is to inform you that US FDA had conducted a Bioresearch Monitoring (BIMO) inspection at the Company''s Bioequivalence Centre located at Taloja, Maharashtra from 10th March, 2025 to ....
Regulatory Filings
2025-03-13 English
This is to inform you that the Company launches generic empagliflozin and its combinations in India under the brand name "Empanorm". A press release in this regard is enclosed herewith. Kindly ....
Regulatory Filings
2025-03-12 English
Press Release
Regulatory Filings
2025-03-12 English
Appointment
Board/Management Information
2025-03-10 English
This is to inform you that Mr. Shirish Purushotham Ambulgekar has been appointed at the senior management position of the Company w.e.f. 10th March, 2025.
Regulatory Filings
2025-03-10 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 17th March, 2025, 18th March, 2025, 19th March, 2025, 24th March, 2025 and 25th March, 2025.
Regulatory Filings
2025-03-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2025-03-10 English
Pursuant to Regulation 30 of SEBI LODR Regulations, and further to our earlier intimation dated 28th December, 2024 this is to inform you that the Company has received further order passed ....
Regulatory Filings
2025-03-01 English
Action(s) initiated or orders passed
Regulatory Filings
2025-03-01 English
Action(s) initiated or orders passed
Regulatory Filings
2025-03-01 English
Pursuant to Regulation 30 0f SEBI LODR Regulations, 2015, this is to inform that the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-03-01 English
This is to inform you that Mr. Sanjay Kumar Dipak has been appointed at the senior management position of the Company w.e.f 28th February, 2025.
Regulatory Filings
2025-02-28 English
Appointment
Board/Management Information
2025-02-28 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-02-28 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-28 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-02-28 English
Action(s) initiated or orders passed
Legal Proceedings Report
2025-02-28 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services tax ....
Regulatory Filings
2025-02-28 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-28 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received Orders passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-02-27 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-27 English
Samprada & Nanhamati Singh Family Trust has submitted a letter to Exchange on amendment to trust deed under Regulation 11(5) of The Securities and Exchange Board of India (Substantial ....
Regulatory Filings
2025-02-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-18 English
Please find enclosed herewith the details of investor meeting scheduled to be held 27th February, 2025.
Regulatory Filings
2025-02-18 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-18 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-02-18 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 24th February, 2025.
Regulatory Filings
2025-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-17 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-14 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-02-11 English
Please find enclosed herewith the transcript of "Q3 FY2025 Earnings Conference Call" hosted by the Company on Friday, 07th February, 2025.
Regulatory Filings
2025-02-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-10 English
Please find enclosed herewith the details of investor meeting scheduled to be held 13th February, 2025.
Regulatory Filings
2025-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2025-02-07 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY25 Earnings Conference Call' is available ....
Regulatory Filings
2025-02-07 English
Copy of Newspaper Publication
Notice of Dividend Amount
2025-02-07 English
Pursuant to Regulation 30 and 47 read along with Schedule III of SEBI LODR Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. ....
Regulatory Filings
2025-02-07 English
Updates
Regulatory Filings
2025-02-07 English
PFA unaudited financial results and LRR for quarter and nine months ended 31st Dec, 2024
Regulatory Filings
2025-02-07 English
Integrated Filing- Financial
Regulatory Filings
2025-02-07 English
Please find enclosed herewith Integrated Filing (Financial) Unaudited financial results and LRR for quarter and nine months ended 31st Dec, 24.
Regulatory Filings
2025-02-07 English
General Updates
M&A Activity
2025-02-07 English
This is to inform you that the Company has through a binding term sheet dated 7th Feb, 25 agreed to acquire 100% stake of M/s. Adroit Biomed Limited, a company incorporated in India. Kindly ....
Regulatory Filings
2025-02-07 English
General Updates
M&A Activity
2025-02-07 English
This is to inform you that M/s. Alkem Medtech Pvt Ltd , a wholly owned subsidiary of the Company in India (Alkem Medtech) intends to acquire 100% of share capital of M/s. Bombay Ortho Industries ....
Regulatory Filings
2025-02-07 English
Trading Window
Regulatory Filings
2025-02-07 English
The Financials Results for quarter and nine months ended 31st dec, 24 having communicated to Stock Exchanges today 7th Feb, 25 the trading window shall open on 10th Feb, 25
Regulatory Filings
2025-02-07 English
PFA press release and analyst presentation on Q3FY25 earnings and business updates
Regulatory Filings
2025-02-07 English
Investor Presentation
Interim / Quarterly Report
2025-02-07 English
Financial Result Updates
Regulatory Filings
2025-02-07 English
In continuation of our letter dated 28th Jan, 25 BOD has declared interim dividend at its meeting held on 7th Feb of Rs. 37 per equity share of Rs. 2 each for FY 24-25.
Regulatory Filings
2025-02-07 English
Dividend
Regulatory Filings
2025-02-07 English
Please find enclosed unaudited financial results and LRR for quarter and nine months ended 31st Dec, 2024.
Regulatory Filings
2025-02-07 English
Outcome of Board Meeting
Regulatory Filings
2025-02-07 English
Please find enclosed herewith the Outcome of the Board Meeting dated 7th February, 2025. The meeting of the Board of Directors of the Company commenced at 11.00 am and concluded at 13.40 ....
Regulatory Filings
2025-02-07 English
Press Release
Regulatory Filings
2025-02-04 English
This is to inform you that the Company has announced the launch of Kojiglo serum in India for managing facial hyperpigmentation. A press release in this regard is enclosed herewith. Kindly ....
Regulatory Filings
2025-02-04 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received Orders passed by the statutory authority under the Goods and Services Tax Act, ....
Regulatory Filings
2025-02-04 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2025-02-03 English
Please find enclosed herewith the details of investor meetings scheduled to be held on 12th February, 2025 and 05th March, 2025.
Regulatory Filings
2025-02-03 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-02-03 English
Action(s) initiated or orders passed
Regulatory Filings
2025-02-03 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY25 financial ....
Regulatory Filings
2025-01-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2025-01-30 English
In continuation of our earlier intimation dated 17th December, 2024, we would like to inform you that today i.e. 29th January, 2025, the allotment of equity shares in favour of the Company ....
Regulatory Filings
2025-01-29 English
General Updates
Capital/Financing Update
2025-01-29 English
The record date for the purpose of payment of Interim Dividend for financial year 2024-2025 would be Friday, 14th February, 2025, subject to declaration of the said Interim Dividend by ....
Regulatory Filings
2025-01-28 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-28 English
Record Date
Regulatory Filings
2025-01-28 English
The record date for the purpose of payment of Interim Dividend for financial year 2024-2025 would be, Friday, 14th February, 2025, subject to declaration of the said Interim Dividend by ....
Regulatory Filings
2025-01-28 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2025-01-28 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2025-01-28 English
General Updates
Capital/Financing Update
2025-01-07 English
This is to inform you that the Company has entered into a Business Transfer Agreement dated 06 January, 2025, with M/s. Rubicon Research Limited, the details of which are enclosed herewith.
Regulatory Filings
2025-01-07 English
Action(s) initiated or orders passed
Regulatory Filings
2025-01-07 English
Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax ....
Regulatory Filings
2025-01-07 English
Updates
Regulatory Filings
2025-01-02 English
This is to inform you that the Company has received the information from the Registrar and Share Transfer Agent (RTA) regarding change in its name from "Link Intime India Private Limited" ....
Regulatory Filings
2025-01-02 English